Manganese produce a parkinsonism-like illness characterized by movement abnormalities. This condition is not responsive to typical therapies used in the treatment of PD, suggesting an alternative pathway than the typical dopaminergic loss within the substantia nigra. Manganese may accumulate in the basal ganglia, leading to the abnormal movements. A mutation of the SLC30A10 gene, a manganese efflux transporter necessary for decreasing intracellular Mn, has been linked with the development of this Parkinsonism-like disease. The Lewy bodies typical to PD are not seen in Mn-induced parkinsonism. Animal experiments have given the opportunity to examine the consequences of manganese overexposure under controlled conditions.
Manganese heptoxide with sulfuric acid to give the remarkable manganyl(VII) cation , which is isoelectronic with CrO MnO decomposes near room temperature, explosively so above 55 °C. The explosion can be initiated by striking the sample or by its exposure to oxidizable organic compounds. The products are MnO and O. Ozone is also produced, giving a strong smell to the substance. The ozone can spontaneously ignite a piece of paper impregnated with an alcohol solution. The production of manganese heptoxide is an undesirable byproduct in many situations. Manganese heptoxide Manganese(VII) oxide (manganese heptoxide) is an inorganic compound with the formula MnO. This